Comparing Bayesian and Frequentist Approaches for Multiple Outcome Mixed Treatment Comparisons
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Objectives. Bayesian statistical methods are increasingly popular as a tool for meta-analysis of clinical trial data involving both direct and indirect treatment comparisons. However, appropriate selection of prior distributions for unknown model parameters and checking of consistency assumptions required for modeling remain particularly challenging. We compared Bayesian and traditional frequentist statistical methods for mixed treatment comparisons with multiple binary outcomes. Data. We searched major electronic bibliographic databases, Food and Drug Administration reviews, trial registries, and research grant databases up to December 2011 to find randomized studies published in English that examined drugs for female urgency urinary incontinence (UI) on continence, improvement in UI, and treatment discontinuation due to harm. Methods. We describe and fit fixed and random effects models in both Bayesian and frequentist statistical frameworks. In a hierarchical model of 8 treatments, we separately analyze 1 safety and 2 efficacy outcomes. We produce Bayesian and frequentist treatment ranks and odds ratios across all drug v placebo comparisons, as well as Bayesian probabilities that each drug is best overall through a weighted scoring rule that trades off efficacy and safety. Results. In our study, Bayesian and frequentist random effects models generally suggest the same drugs as most attractive, although neither suggests any significant differences between drugs. However, the Bayesian methods more consistently identify one drug (propiverine) as best overall, produce interval estimates that are generally better at capturing all sources of uncertainty in the data, and also permit attractive “rankograms” that visually capture the probability that each drug assumes each possible rank. Conclusions. Bayesian methods are more flexible and their results more clinically interpretable, but they require more careful development and specialized software.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gelman, A. (2006) · Bayesian Analysis · doi:10.1214/06-ba117a · Cited by 4,050 · cited 1×
“01,2) prior is adopted.(24) For the heterogeneous model, a more complex prior for sBk is introduced; namely, we set log sxy 1⁄4 log s0 1 vxy, where s0;Uniformð0:01; 2Þ; vxy;Nð0;c(2)Þ, and c is a constant chosen to reflect a certain amount of heterogeneity among arms.”
BackgroundSalanti, G., Ades, A. E., & Ioannidis, J. P. A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.03.016 · Cited by 3,766
What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse data
J. Sweeting, M., J. Sutton, A., & C. Lambert, P. (2004) · Statistics in Medicine · doi:10.1002/sim.1761 · Cited by 1,734 · cited 1×
“5 successes to an arm containing zero events or simply exclude studies with no events at all, but both methods have potentially harmful impacts on the asymptotic approximations these programs use to determine statistical significance.(33) Although we could not fit the frequentist heterogeneous random effects model wit…”
MethodNetwork meta‐analysis for indirect treatment comparisons
Lumley, T. (2002) · Statistics in Medicine · doi:10.1002/sim.1201 · Cited by 1,206
Bayesian approaches to random-effects meta-analysis: a comparative study
Smith, T. C., Spiegelhalter, D. J., & Thomas, A. (1995) · Statistics in Medicine · doi:10.1002/sim.4780142408 · Cited by 568
Multivariate Random-effects Meta-regression: Updates to Mvmeta
White, I. R. (2011) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x1101100206 · Cited by 400
Cited by
GetReal in network meta-analysis: a review of the methodology
Efthimiou, O., Debray, T. P. A., van Valkenhoef, G., Trelle, S., Panayidou, K., Moons, K. G. M., Reitsma, J. B., Shang, A., Salanti, G., & on behalf of GetReal Methods Review Group (2016) · Research Synthesis Methods · doi:10.1002/jrsm.1195 · Cited by 401
“Hong et al. (2013a) presented a model for multiple outcomes that does not take into account within-study correlations.”
BackgroundMethodInfluentialNetwork Meta-Analysis Using R: A Review of Currently Available Automated Packages
Neupane, B., Richer, D., Bonner, A. J., Kibret, T., & Beyene, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115065 · Cited by 362
Qaseem, A., Barry, M. J., Kansagara, D., & for the Clinical Guidelines Committee of the American College of Physicians (2016) · Annals of Internal Medicine · doi:10.7326/m15-2570 · Cited by 279
Systematic Reviews and Cancer Research: a Suggested Stepwise Approach
Kelley, G. A., & Kelley, K. S. (2018) · BMC Cancer · doi:10.1186/s12885-018-4163-6 · Cited by 13
Metadata
- Authors
- Hong, H., Carlin, B. P., Shamliyan, T. A., Wyman, J. F., Ramakrishnan, R., Sainfort, F., & Kane, R. L.
- Venue
- Medical Decision Making
- Publisher
- SAGE Publications
- Published
- 2013-04-02
- Volume
- 33
- Issue
- 5
- Pages
- 702-714
- ISSN
- 0272-989X (ISSN-L)
- 1552-681X
- OpenAlex
- W2004943949
- Cited by
- 91
- References
- 6
- FWCI
- 6.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparing Bayesian and Frequentist Approaches for Multiple Outcome Mixed Treatment Comparisons. https://app.cochat.ai/papers/10.1177/0272989x13481110
- The paper
- Hong, H., Carlin, B. P., Shamliyan, T. A., Wyman, J. F., Ramakrishnan, R., Sainfort, F., & Kane, R. L. (2013). Comparing Bayesian and Frequentist Approaches for Multiple Outcome Mixed Treatment Comparisons. Medical Decision Making. https://doi.org/10.1177/0272989x13481110
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.